Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$18.21 - $24.5 $1.5 Million - $2.02 Million
-82,370 Reduced 89.04%
10,136 $191,000
Q1 2024

May 02, 2024

SELL
$18.65 - $26.52 $127,360 - $181,105
-6,829 Reduced 6.87%
92,506 $2.05 Million
Q4 2023

Jan 26, 2024

BUY
$16.53 - $21.42 $700,276 - $907,436
42,364 Added 74.36%
99,335 $2.11 Million
Q3 2023

Nov 09, 2023

SELL
$20.08 - $25.39 $79,215 - $100,163
-3,945 Reduced 6.48%
56,971 $1.15 Million
Q2 2023

Aug 11, 2023

SELL
$24.77 - $29.9 $106,808 - $128,928
-4,312 Reduced 6.61%
60,916 $1.52 Million
Q1 2023

May 04, 2023

SELL
$25.95 - $36.95 $69,104 - $98,397
-2,663 Reduced 3.92%
65,228 $1.82 Million
Q4 2022

Feb 10, 2023

BUY
$24.79 - $30.86 $35,127 - $43,728
1,417 Added 2.13%
67,891 $1.77 Million
Q3 2022

Nov 08, 2022

SELL
$24.62 - $32.44 $76,445 - $100,726
-3,105 Reduced 4.46%
66,474 $1.73 Million
Q2 2022

Aug 10, 2022

BUY
$19.74 - $29.01 $22,444 - $32,984
1,137 Added 1.66%
69,579 $1.9 Million
Q1 2022

May 02, 2022

SELL
$26.68 - $41.63 $58,055 - $90,586
-2,176 Reduced 3.08%
68,442 $1.83 Million
Q4 2021

Feb 03, 2022

SELL
$33.67 - $43.44 $12,558 - $16,203
-373 Reduced 0.53%
70,618 $2.83 Million
Q3 2021

Nov 10, 2021

SELL
$30.65 - $35.68 $43,369 - $50,487
-1,415 Reduced 1.95%
70,991 $2.32 Million
Q2 2021

Aug 06, 2021

SELL
$34.33 - $44.68 $76,487 - $99,547
-2,228 Reduced 2.99%
72,406 $2.5 Million
Q1 2021

May 13, 2021

SELL
$40.81 - $53.88 $127,898 - $168,859
-3,134 Reduced 4.03%
74,634 $3.21 Million
Q4 2020

Feb 12, 2021

SELL
$36.63 - $47.63 $40,879 - $53,155
-1,116 Reduced 1.41%
77,768 $3.39 Million
Q3 2020

Nov 13, 2020

SELL
$30.09 - $43.02 $238,162 - $340,503
-7,915 Reduced 9.12%
78,884 $3.06 Million
Q2 2020

Aug 06, 2020

SELL
$27.76 - $33.42 $151,403 - $182,272
-5,454 Reduced 5.91%
86,799 $2.81 Million
Q1 2020

May 11, 2020

SELL
$20.69 - $37.79 $73,221 - $133,738
-3,539 Reduced 3.69%
92,253 $2.76 Million
Q4 2019

Feb 11, 2020

SELL
$32.75 - $41.43 $22,630 - $28,628
-691 Reduced 0.72%
95,792 $3.29 Million
Q3 2019

Nov 14, 2019

BUY
$33.73 - $46.27 $42,600 - $58,439
1,263 Added 1.33%
96,483 $3.25 Million
Q2 2019

Aug 12, 2019

BUY
$29.6 - $40.93 $1,776 - $2,455
60 Added 0.06%
95,220 $3.9 Million
Q1 2019

May 13, 2019

BUY
$27.85 - $38.09 $48,152 - $65,857
1,729 Added 1.85%
95,160 $2.96 Million
Q3 2018

Nov 13, 2018

SELL
$35.69 - $47.65 $24,233 - $32,354
-679 Reduced 0.72%
93,431 $3.64 Million
Q2 2018

Aug 09, 2018

BUY
$28.41 - $42.41 $2.67 Million - $3.99 Million
94,110 New
94,110 $3.48 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.39B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.